Curevac N V Asset Turnover Ratio (CVAC), as of second quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Curevac N v   (NASDAQ: CVAC)
 

Curevac N V Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2025, Curevac N V 's asset turnover ratio sequentially decreased to 1.38 in the second quarter (Jun 30 2025), but remained above the company's average. For every Dollar on the Balance Sheet, Curevac N V realized $1.38 in annual sales.

Within sector 53 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2025 compared to the preceding quarter from 474 to 1869.

Asset Turnover Ratio Definition



CVAC Asset Turnover Ratio (Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
0
III. Quarter
0
II. Quarter
Y / Y Asset Change -4.37 % -5.42 % 1.75 % 1.81 % 1.47 %
Y / Y Revenue Change -90.92 % -93 % 895.54 % 2924.68 % 88.34 %
Asset Turnover Ratio (TTM) 1.38 1.39 1.38 0.75 0.13
CVAC's Total Ranking # 1869 # 474 # # #
Seq. Asset Change 1.18 % -5.42 % -0.06 % -0 % 0.07 %
Seq. Revenue Change 50.11 % -99.84 % 10.46 % 3391.52 % 15.72 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 54
Healthcare Sector # 223
Overall Market # 1869

Asset Turnover Ratio Statistics
High Average Low
0.67 0.27 0.07
(Dec 31 2024)   (Dec 31 2023)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
Reshape Lifesciences Inc  3.84 $ 5.503  Millions$ 1.432  Millions
Lifevantage Corp  3.36 $ 227.666  Millions$ 67.739  Millions
Atara Biotherapeutics Inc   3.33 $ 291.685  Millions$ 87.686  Millions
Lifemd Inc   3.31 $ 244.476  Millions$ 73.959  Millions
Agilon Health Inc   3.16 $ 5,901.182  Millions$ 1,867.788  Millions
Interpace Biosciences Inc   3.12 $ 43.468  Millions$ 13.915  Millions
Zeo Scientifix Inc   3.05 $ 4.789  Millions$ 1.570  Millions
The Oncology Institute Inc   2.51 $ 424.376  Millions$ 168.925  Millions
Biotricity Inc   2.49 $ 14.237  Millions$ 5.728  Millions
Biofrontera Inc   2.46 $ 47.521  Millions$ 19.337  Millions
Escalon Medical Corp   2.45 $ 12.046  Millions$ 4.921  Millions
Healthcare Services Group Inc   2.19 $ 1,772.114  Millions$ 808.444  Millions
Longduoduo Co Ltd  2.13 $ 4.263  Millions$ 2.001  Millions
Rosecliff Acquisition Corp I  2.11 $ 28.320  Millions$ 13.401  Millions
Integrated Biopharma Inc  2.08 $ 53.562  Millions$ 25.737  Millions
Champions Oncology Inc   1.99 $ 56.878  Millions$ 28.566  Millions
Hims and Hers Health Inc   1.97 $ 2,012.312  Millions$ 1,019.773  Millions
P3 Health Partners Inc   1.87 $ 1,461.823  Millions$ 783.052  Millions
Nature s Sunshine Products inc   1.85 $ 459.719  Millions$ 248.441  Millions
Vycor Medical Inc   1.83 $ 1.779  Millions$ 0.973  Millions
Progyny Inc   1.80 $ 1,241.444  Millions$ 689.577  Millions
Quipt Home Medical Corp   1.74 $ 422.961  Millions$ 242.700  Millions
Encision Inc   1.72 $ 6.527  Millions$ 3.796  Millions
International Stem Cell Corporation  1.71 $ 9.201  Millions$ 5.381  Millions
Regen Biopharma Inc   1.69 $ 0.291  Millions$ 0.172  Millions
Marpai Inc  1.65 $ 23.673  Millions$ 14.316  Millions
Cv Sciences Inc   1.62 $ 12.957  Millions$ 8.007  Millions
Privia Health Group Inc   1.60 $ 1,900.071  Millions$ 1,184.357  Millions
Kewaunee Scientific Corporation  1.60 $ 263.299  Millions$ 164.346  Millions
Innovage Holding Corp   1.60 $ 853.699  Millions$ 534.720  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.